Functional Genomic Study on Atrial Fibrillation Using cDNA Microarray and Two-Dimensional Protein Electrophoresis Techniques and Identification of the Myosin Regulatory Light Chain Isoform Reprogramming in Atrial Fibrillation-Reference-Cited by-同舟云学术

Functional Genomic Study on Atrial Fibrillation Using cDNA Microarray and Two-Dimensional Protein Electrophoresis Techniques and Identification of the Myosin Regulatory Light Chain Isoform Reprogramming in Atrial Fibrillation

Published:2004-02 Issue:2 Volume:15 Page:214-223
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:J Cardiovasc Electrophysiol

Author:

LAI LING-PING,LIN JIUNN-LEE,LIN CHICH-SHENG,YEH HUEI-MING,TSAY YEOU-GUANG,LEE CHWEN-FANG,LEE HSIAO-HUI,CHANG ZEE-FEN,HWANG JUEY-JEN,SU MING-JAI,TSENG YUNG-ZU,HUANG SHOEI K. STEPHEN

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1540-8167.2004.03423.x/fullpdf

Reference24 articles.

1. Atrial Fibrillation Begets Atrial Fibrillation

2. Measurement of Funny Current (If) Channel mRNA in Human Atrial Tissue: Correlation with Left Atrial Filling Pressure and Atrial Fibrillation

3. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban

4. Regulation of Angiotensin II Receptor Subtypes During Atrial Fibrillation in Humans

5. Atrial L-type Ca 2+ -channel, β-adrenoreceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications;Nature Reviews Cardiology;2024-05-30

2. Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF);Frontiers in Cardiovascular Medicine;2022-08-25

3. Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy;Antiarrhythmic Drugs;2020

4. Proteomics and transcriptomics in atrial fibrillation;Herzschrittmachertherapie + Elektrophysiologie;2018-01-09

5. Perioperative Genomics;Genomic and Precision Medicine;2018